Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

3.500

-0.250 (-6.67%)

At close: Nov 13, 2026, 4:00 PM EST

3.430

-0.070 (-2.00%)

After-hours: Nov 13, 2026, 5:28 PM EST

Starling Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	620.45	502.73	393.41	324.24	252.48	203
Revenue Growth	34.58%	27.79%	21.33%	28.42%	24.37%	8.26%
Cost of Revenue	516.53	426.29	339.42	264.67	200.39	162.16
Gross Profit	103.92	76.44	54	59.57	52.09	40.85
Selling, General & Admin	118.33	105.57	107.83	113.85	119.69	82.89
Operating Expenses	124.93	112.52	114.12	119.72	124.1	86.23
Operating Income	-21.02	-36.08	-60.12	-60.15	-72.01	-45.38
Interest Expense	-10.41	-11.28	-7.5	-6.78	-4.08	-0.32
Other Non Operating Income (Expenses)	4.55	-13.38	2.82	-0.35	25.9	3.71
EBT Excluding Unusual Items	-26.87	-60.74	-64.8	-67.28	-50.19	-41.99
Merger & Restructuring Charges	-	-	-	-	-	-0.48
Impairment of Goodwill	-	-	-	-16.87	-9.94	-
Gain (Loss) on Sale of Investments	0.01	0.01	0.13	0.24	0.64	-
Other Unusual Items	-8.68	-	-	0.8	59.4	30.87
Pretax Income	-35.54	-60.74	-64.66	-83.1	-0.09	-11.6
Income Tax Expense	-	-0.13	-	-0.04	-0.24	-0.67
Net Income	-35.54	-60.61	-64.66	-83.07	0.15	-10.93
Preferred Dividends & Other Adjustments	-5.51	-10.3	-11.66	-15.19	0.08	-0.3
Net Income to Common	-30.03	-50.31	-53.01	-67.88	0.07	-10.63
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	103	92	75	74	73	66
Shares Outstanding (Diluted)	103	92	75	74	81	66
Shares Change	19.64%	23.11%	1.76%	-8.51%	21.70%	12.03%
EPS (Basic)	-0.29	-0.54	-0.71	-0.92	0.00	-0.16
EPS (Diluted)	-0.29	-0.54	-0.71	-0.92	-0.21	-0.16
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	18.83	-27.79	-30.33	-40.88	-67.29	-35.53
Free Cash Flow Per Share	0.18	-0.30	-0.40	-0.55	-0.83	-0.54
Gross Margin	16.75%	15.20%	13.73%	18.37%	20.63%	20.12%
Operating Margin	-3.39%	-7.18%	-15.28%	-18.55%	-28.52%	-22.36%
Profit Margin	-4.84%	-10.01%	-13.47%	-20.93%	0.03%	-5.24%
Free Cash Flow Margin	3.03%	-5.53%	-7.71%	-12.61%	-26.65%	-17.50%
EBITDA	-14.41	-29.14	-53.83	-54.28	-67.6	-42.04
EBITDA Margin	-2.32%	-5.80%	-13.68%	-16.74%	-26.77%	-20.71%
D&A For EBITDA	6.61	6.94	6.29	5.87	4.41	3.34
EBIT	-21.02	-36.08	-60.12	-60.15	-72.01	-45.38
EBIT Margin	-3.39%	-7.18%	-15.28%	-18.55%	-28.52%	-22.36%
Revenue as Reported	620.45	502.73	393.41	324.24	252.48	203

SEC Filings: 10-K · 10-Q